The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses
Name:
s12916-023-02823-9.pdf
Size:
1.634Mb
Format:
PDF
Description:
Final Published Version
Affiliation
Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of ArizonaIssue Date
2023-03-29
Metadata
Show full item recordPublisher
BioMed Central LtdCitation
Liu, Z., Al Amer, F.M., Xiao, M. et al. The normality assumption on between-study random effects was questionable in a considerable number of Cochrane meta-analyses. BMC Med 21, 112 (2023). https://doi.org/10.1186/s12916-023-02823-9Journal
BMC MedicineRights
© The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: Studies included in a meta-analysis are often heterogeneous. The traditional random-effects models assume their true effects to follow a normal distribution, while it is unclear if this critical assumption is practical. Violations of this between-study normality assumption could lead to problematic meta-analytical conclusions. We aimed to empirically examine if this assumption is valid in published meta-analyses. Methods: In this cross-sectional study, we collected meta-analyses available in the Cochrane Library with at least 10 studies and with between-study variance estimates > 0. For each extracted meta-analysis, we performed the Shapiro–Wilk (SW) test to quantitatively assess the between-study normality assumption. For binary outcomes, we assessed between-study normality for odds ratios (ORs), relative risks (RRs), and risk differences (RDs). Subgroup analyses based on sample sizes and event rates were used to rule out the potential confounders. In addition, we obtained the quantile–quantile (Q–Q) plot of study-specific standardized residuals for visually assessing between-study normality. Results: Based on 4234 eligible meta-analyses with binary outcomes and 3433 with non-binary outcomes, the proportion of meta-analyses that had statistically significant non-normality varied from 15.1 to 26.2%. RDs and non-binary outcomes led to more frequent non-normality issues than ORs and RRs. For binary outcomes, the between-study non-normality was more frequently found in meta-analyses with larger sample sizes and event rates away from 0 and 100%. The agreements of assessing the normality between two independent researchers based on Q–Q plots were fair or moderate. Conclusions: The between-study normality assumption is commonly violated in Cochrane meta-analyses. This assumption should be routinely assessed when performing a meta-analysis. When it may not hold, alternative meta-analysis methods that do not make this assumption should be considered. © 2023, The Author(s).Note
Open access journalISSN
1741-7015PubMed ID
36978059Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1186/s12916-023-02823-9
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License.
Related articles
- Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
- Authors: Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P
- Issue date: 2022 Feb 1
- Evaluation of the Normality Assumption in Meta-Analyses.
- Authors: Wang CC, Lee WC
- Issue date: 2020 Mar 2
- Heterogeneity estimation in meta-analysis of standardized mean differences when the distribution of random effects departs from normal: A Monte Carlo simulation study.
- Authors: Blázquez-Rincón D, Sánchez-Meca J, Botella J, Suero M
- Issue date: 2023 Jan 17
- A graphical approach to assess the goodness-of-fit of random-effects linear models when the goal is to measure individual benefits of medical treatments in severely ill patients.
- Authors: Wang Z, Diaz FJ
- Issue date: 2020 Jul 20

